Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 63,350 | reported | 24 Mar 2026 | tx 1+63,350 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 63,350 | 0.00 USD | deriv |